Compliance Actions (Biologics)
CBER carries out a wide range of compliance and surveillance activities during the “life cycle” of biological products
Recommend0 recommendationsPublished in US National Health Agency Sources
Related Articles
How ADHS regulates sober living homes and behavioral health residential facilities
In Part 1 of our Licensing blog series, we shared what a sober living home (SLH) actually is. We also explained other types of homes that are often confused for sober living homes, including behavioral health residential facilities (BHRF), which are also licensed by the Arizona Department of Health Services (ADHS). In this installment of […]
COVID Surveillance Project
The Centers for Disease Control and Prevention (CDC)’s Division of Global Health Protection has been collaborating with the Ministry of Public Health and provincial offices in Thailand to respond to the COVID-19 pandemic by conducting surveillance to identify SARS-CoV-2 infection among febrile patients aged 2 years presenting to six hospitals along the Thai-Myanmar and Thai-Laos borders. This work is helping to strengthen surveillance by expanding geographic coverage of specimen and data collection, increase disease monitoring and use for decision making, and understand patients knowledge and perceptions about COVID to inform mitigation strategies in underserved settings in Thailand. CDC’s influenza work at its Influenza Regional Hub in Thailand is focused on enhanced surveillance and laboratory capacity for the timely detection and characterization of viruses with pandemic potential, as well as efficient detection of seasonal influenza viruses, respiratory viruses, and novel emerging variants. CDC collaborates with and provides technical assistance to Thailand, Bangladesh, Lao PDR, and Indonesia. In Thailand, the CDC influenza team supports multiple projects, including: a network of sentinel influenza surveillance sites, laboratory testing and sequencing capacities, clinical trials of locally-produced vaccine, updating clinical guidelines for influenza treatment, research to quantify protective effects of influenza vaccination in vulnerable populations, and pandemic preparedness and rapid response trainings. During the SARS CoV-2 pandemic, the influenza team leveraged surveillance platforms and cohort studies for influenza to monitor transmission of SARS CoV-2 and vaccine effectiveness. Data were used to inform the public health response to the pandemic.Video Transcript: https://www.cdc.gov/globalhealth/video/transcripts/covid-surveillance-project-thailand-transcript2.docx
This video can also be viewed at
https://www.cdc.gov/globalhealth/video/2022-06-06-cares-act/covid-surveillance-project-thailand-lowres2.mp4
CBER Biologics Effectiveness and Safety (BEST) System
This is the main page for CBER’s Biologics Effectiveness and Safety (BEST) System.
What Is Having Long COVID-19 Really Like?
It wasn’t too long ago that COVID-19 threw life into chaos. Businesses shut their doors. Food and supplies ran low. We were separated from our loved ones and trapped indoors. Hospitals dealt with rising demand. Lives were lost. Years have passed since the pandemic and we’ve tried to distance ourselves from a time when distillers …
The post What Is Having Long COVID-19 Really Like? appeared first on Salud America.
Clinical Trials Bring Researchers Closer to Long COVID Treatments
Most people with COVID-19 get better within a few days to a few weeks after COVID-19 infection. But some people, including many Latinos, develop long COVID. Long COVID remains an unresolved threat to the health of Latinos and all people. While health experts don’t yet fully understand long COVID symptoms and risk factors, progress is …
The post Clinical Trials Bring Researchers Closer to Long COVID Treatments appeared first on Salud America.